This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
2h zacks - 1
Chicago, IL – August 21, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Timmons Gold Corp (ALO - Free Report) , Northern Dynasty Minerals Ltd. (NAK - Free Report) , New Gold Inc. (NGD - Free Report) , Sibanye Gold Limited (SBGL - Free Report) and Pershing Gold Corporation (PGLC - Free Report) .
VRTX NGD FIX NGDAF RDN MDR NGD JOUT CCBG NDMWF SBGL.WI BSTC MLNX NAK ADM PGLC MCDFF NSIT
After a blockbuster start to the year, gold has fallen out of investors’ favor, thanks to rising interest rates and a strong dollar. The yellow metal logged in the sixth consecutive weekly decline and the worst weekly drop since December, shedding 2.2% last week. This followed the metal’s fourth consecutive monthly decline in July that represents the longest stretch of losses since 2013.
SBGL NDMWF SBGL.WI NGD ALO NGDAF NAK PGLC NGD
2018-08-20 reuters - 1
Aug 20 (Reuters) - Canada’s main stock index rose on Monday as rising metal prices led to gains in material stocks, with hopes of resolution in the U.S.-China trade dispute boosting the sentiment.
NGD ABX CROJF ACBFF NGDAF K COP NGD CGC TWMJF ACB KGC CNQ WEED FQVLF FQM ABX
After a blockbuster start to the year, gold has fallen out of investors’ favor, thanks to rising interest rates and a strong dollar. The yellow metal logged in the sixth consecutive weekly decline and the worst weekly drop since December, shedding 2.2% last week. This followed the metal’s fourth consecutive monthly decline in July that represents the longest stretch of losses since 2013. Notably, the bullion remained near 19-month lows and has tumbled 14% since its peak in April.
NDMWF NGD SBGL.WI NAK NGDAF NGD PGLC
(Reuters) - Canada’s main stock index slipped on Friday after a much stronger-than-expected inflation data bolstered expectations of an interest rate hike as early as next month.
ACBFF NGDAF CG NGD CAGDF APH BAM ABX WPM BAMGF NGD ABX LYDIF MFC ACB 0945 MFC APHQF BAMKF
Good day, everyone, and welcome to the Royal Gold 2018 Full-Year and Fourth Quarter Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions]. After today’s presentation, there will be an opportunity to ask questions [Operator Instructions]. And please note that today’s event is being recorded.
RGLD CTGO NGD NGDAF NGD RGL GSC
SAN FRANCISCO, July 25 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 30.63 points, or 0.19 percent, to 16,420.76. * Leading the index were Toromont Industries Ltd, up 14.7 percent, FirstService Corp, up 6.8 percent, and Pretium Resources Inc , higher by 5.5 percent. * Lagging shares were Western Forest Products Inc, down 4.0 percent, Interfor Corp, down 3.5 percent, and CES Energy Solutions Corp, lower by 3.
WFSTF NGD TMTNF IFSPF ACBFF MEG NGDAF PVG NGD ACB PVG MEGEF FSV WEF
VANCOUVER, British Columbia, July 18, 2018 (GLOBE NEWSWIRE) -- Group Ten Metals Inc. (TSX-V:PGE) (US OTC:PGEZF) (FSE:5D32) (the “Company” or “Group Ten”) is pleased to provide an update on the Company’s Black Lake-Drayton gold project, located in the Rainy River district of Northwest Ontario, Canada, including the completion of all outstanding earn-in requirements on two of the claim blocks. The Ontario asset complements Group Ten’s core Stillwater West project with a large and highly prospective land position which is strategically located beside advanced-stage projects in a world-class high-grade gold district.
DCGCF PGE NGD PGEZF TSRMF NGDAF NCPCF TML FFMGF NGD
We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.
WPM NGD GFI.WI ABX NEM NGDAF K GDX NGD SLW SLW ELD KGC GFI GFIOF EGO ABX
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...